|
1 |
27 08 2026 |
JNCH to hold 13th Niryat Samvaad on September 9 to address exporters grievances |
Pharmabiz |
India |
|
2 |
27 08 2026 |
Panel asks Centre to review regulatory measures on over-the-counter availability of nephrotoxic drugs |
Pharmabiz |
India |
|
3 |
27 08 2026 |
SIT formation is a double-edged sword in spurious drug investigations: Dr Jagashetty |
Pharmabiz |
India |
|
4 |
27 08 2026 |
LUB asks CDSCO to highlight the fact that 97% of the drugs are standard quality |
Pharmabiz |
India |
|
5 |
26 08 2026 |
Bulk drug exports grew 14.17% in Q1 FY27, imports grew 2.75% |
Pharmabiz |
India |
|
6 |
26 08 2026 |
BDCDA urges CDSCO to allow details like batch number, expiry & MRP printed on front portion of drug packs |
Pharmabiz |
India |
|
7 |
26 08 2026 |
Regulators expect drug manufacturers to understand toxicological significance of impurities: Expert |
Pharmabiz |
India |
|
8 |
26 08 2026 |
IRGMA seeks tighter regulation and traceability of imported medical gloves |
Pharmabiz |
India |
|
9 |
26 08 2026 |
Natco Pharma invests US$ 14 million in eGenesis |
Pharmabiz |
India |
|
10 |
26 08 2026 |
Aurigene inks long-term manufacturing and supply pact with a leading global pharma company |
Pharmabiz |
India |
|
11 |
26 08 2026 |
Influenza cases push up sales of anti-infectives, painkillers across India |
Business Standard |
India |
|
12 |
26 08 2026 |
Dr Reddy’s wins marketing approval for Abatacept biosimilar in India |
Health world (Economic Times) |
India |
|
13 |
26 08 2026 |
Biocon bags marketing approval for Pegfilgrastim biosimilar in Japan |
Health world (Economic Times) |
India |
|
14 |
25 08 2026 |
SEC recommends waiver of BE, CT studies on generic lenacapavir for HIV prevention in India |
Pharmabiz |
India |
|
15 |
25 08 2026 |
DGFT automates EO extension process to ease compliance for pharma exporters |
Pharmabiz |
India |
|
16 |
25 08 2026 |
Health ministry notifies exemption for investigational medical devices approved in EU |
Pharmabiz |
India |
|
17 |
25 08 2026 |
Delhi DC dept issues advisory against deceptive discount boards on RDCA representation |
Pharmabiz |
India |
|
18 |
25 08 2026 |
State Drug Alert : CDSCO flags 199 samples including Paracetamol , Pantoprazole Cefixime as Not of Standard Quality |
Medical Dialogues |
India |
|
19 |
25 08 2026 |
Indian Pharma giants may resist trump tariff pressure as US depends on cheap generics |
Medical Dialogues |
India |
|
20 |
25 08 2026 |
FESA 2026 highlights fire and safety challenges in pharma sector |
Telangana Today |
India |
